Insiders · Profile

Delfini Lisa

Chief Financial Officer at Trevi Therapeutics. Filing since 13 Feb 2023. CIK 0001873253

Company

Date

Role

Action

Shares

Amount

Of holding

TRVI Trevi Therapeutics, Inc.

22 May 2024

Chief Financial Officer

Sold at will

4,350

$11.48K

7.5%

TRVI Trevi Therapeutics, Inc.

11 Oct 2023

Chief Financial Officer

Sold on a plan

785

$1.59K

2.1%

TRVI Trevi Therapeutics, Inc.

11 Sep 2023

Chief Financial Officer

Sold on a plan

711

$1.56K

2.0%

TRVI Trevi Therapeutics, Inc.

11 Aug 2023

Chief Financial Officer

Sold on a plan

682

$1.61K

2.0%

TRVI Trevi Therapeutics, Inc.

11 Jul 2023

Chief Financial Officer

Sold on a plan

687

$1.61K

2.2%

TRVI Trevi Therapeutics, Inc.

12 Jun 2023

Chief Financial Officer

Sold on a plan

610

$1.61K

2.0%

TRVI Trevi Therapeutics, Inc.

11 May 2023

Chief Financial Officer

Sold on a plan

562

$1.62K

2.0%

TRVI Trevi Therapeutics, Inc.

11 Apr 2023

Chief Financial Officer

Sold on a plan

840

$1.54K

3.1%

TRVI Trevi Therapeutics, Inc.

13 Mar 2023

Chief Financial Officer

Sold, plan not stated

892

$1.56K

3.5%

TRVI Trevi Therapeutics, Inc.

13 Feb 2023

Chief Financial Officer

Sold, plan not stated

8,474

$20.76K

26.6%

10 decisions on file.